搜尋結果
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, ...
ACCESSWIRE· 1 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
Gilead's Path to Equitable Global COVID-19 Treatment Access
ACCESSWIRE· 1 年前NORTHAMPTON, MA / ACCESSWIRE / November 2, 2022 / Gilead Sciences Since the beginning of the ...